HB 1828 requires health insurance plans in Pennsylvania to cover all recommended vaccines without requiring patients to pay out-of-pocket costs like copays or deductibles. It directly affects insurance companies by mandating this coverage and patients who rely on insurance for routine immunizations (e.g., childhood vaccines, flu shots). The bill adds penalties for insurers that fail to comply with the coverage requirement. This policy change ensures broader access to vaccines by removing financial barriers under insurance plans.
HB 157 creates state grants to help healthcare entities in rural counties or designated medically underserved areas cover the student loan debt of their employed healthcare practitioners. The grants would be paid directly to the healthcare facilities (like clinics or hospitals), not to individual providers, to offset the cost of practitioners' education debt. This aims to support recruitment and retention of healthcare workers in areas with limited access to medical services. The program would be funded through state appropriations, targeting facilities serving communities with significant healthcare access challenges.
HB 1212 requires Pennsylvania maternal health programs to provide drug screening and awareness education to patients. It also mandates the inclusion of fatherhood engagement strategies in prenatal care discussions, directly affecting pregnant individuals and their partners receiving maternal health services. The bill imposes specific duties on the Joint State Government Commission to develop and oversee these program requirements. These provisions aim to integrate substance use prevention and family involvement into standard maternal health care protocols.
HB 564 updates Pennsylvania law to establish a new mental health crisis response system. It requires the Department of Human Services to create and operate this system, including training crisis responders and coordinating care. The bill directly affects individuals experiencing mental health crises and the state agencies responsible for emergency mental health services. Key provisions mandate specific duties for DHS to ensure timely, accessible crisis support statewide. The bill passed final passage on July 14, 2025, and is now under review by the Health & Human Services committee.
HB 1697 amends Pennsylvania's Human Services Code to create a state-level False Claims Act, directly affecting healthcare providers, contractors, and organizations receiving state funds (like Medicaid or welfare programs). It makes individuals or entities liable for three times the damages plus penalties if they knowingly submit false claims, make false records, or conceal obligations to the state. The bill establishes "qui tam" lawsuits allowing whistleblowers to sue on behalf of the state and creates a Fraud Prevention and Recovery Account to hold recovered funds. These provisions align Pennsylvania's law with the federal False Claims Act to combat fraud in public spending.
SB 475 creates a framework for Pennsylvania courts to establish specialized "problem-solving" treatment courts (including veterans, drug, mental health, and DUI courts) and modifies probation rules. It allows courts to create "veterans tracks" within existing treatment programs and requires judges to consider a defendant's employment status when sentencing for technical probation violations. The bill specifically permits up to 30 days of incarceration to allow defendants to enter treatment courts instead of imposing full sentences for technical probation violations. This directly affects Pennsylvania courts, probation officers, and individuals on probation who commit minor violations.
HB 1527 updates the existing Rare Disease Advisory Council established in 2017, clarifying its structure and responsibilities. The bill directly affects patients with rare diseases and requires coordination among the Department of Health, Insurance Department, Department of Human Services, and Department of Education. Key provisions mandate the council to advise state agencies on rare disease research, treatment access, insurance coverage, and resource allocation. It also specifies how departments must collaborate on policies impacting rare disease patients, ensuring a unified state approach.
HB 1234 amends Pennsylvania's Human Services Code to require public assistance programs to cover the cost of blood pressure monitors for eligible recipients. This change directly affects individuals enrolled in state public assistance programs who need blood pressure monitoring for health management. The bill adds blood pressure monitors to the list of covered medical equipment under the public assistance program, ensuring these devices are provided without cost to recipients. It does not change eligibility requirements but expands existing coverage to include this specific monitoring tool. The bill passed final passage on July 1, 2025, and was referred to the Health & Human Services committee.
SB 95 amends Pennsylvania's Pharmacy Act to create a 180-day provisional license for pharmacists moving from other states, allowing them to practice without demonstrating competency under Pennsylvania's requirements. It also permits emergency medical services providers to distribute naloxone dose packages for opioid overdose reversal under specific conditions, including a Department of Health standing order and voluntary distribution without liability. Additionally, the bill requires pharmacies to disclose prescription drug prices (brand vs. generic), cost-sharing amounts, and health insurance options upon customer request. These changes aim to improve pharmacist mobility, expand naloxone access, and increase price transparency for consumers.
HB 309 amends Pennsylvania's Osteopathic Medical Practice Act (1978) to update licensing rules for osteopathic physicians and related healthcare providers. It changes registration requirements from annual to biennial (every two years), clarifies rules for visiting team physicians at sports events, and adjusts continuing medical education requirements. The bill directly affects licensed osteopathic physicians, nonresident practitioners, medical students, and healthcare facilities employing osteopathic staff. Signed into law on July 7, 2025 (Act No. 29), it streamlines administrative processes without creating new licensing barriers.
